Literature DB >> 20542011

Cardiovascular disease and bone.

Richard Eastell1, Chris Newman, David C Crossman.   

Abstract

Osteoporosis-related fractures and coronary artery disease, stroke and peripheral artery disease are common conditions, particularly in the elderly. However, there is now strong evidence indicating that these conditions are associated with one another. Furthermore, there are common pathways in the pathophysiology of these two conditions.
Copyright © 2010 Elsevier Inc. All rights reserved.

Entities:  

Mesh：

Year:  2010        PMID： 20542011     DOI： 10.1016/j.abb.2010.06.008

Source DB:  PubMed          Journal:  Arch Biochem Biophys        ISSN： 0003-9861            Impact factor:   4.013


  14 in total

1.  QCT Volumetric Bone Mineral Density and Vascular and Valvular Calcification: The Framingham Study.

Authors:  Jimmy J Chan; L Adrienne Cupples; Douglas P Kiel; Christopher J O'Donnell; Udo Hoffmann; Elizabeth J Samelson
Journal:  J Bone Miner Res       Date:  2015-05-06       Impact factor: 6.741

2.  Vascular tissues are a primary source of BMP2 expression during bone formation induced by distraction osteogenesis.

Authors:  Hidenori Matsubara; Daniel E Hogan; Elise F Morgan; Douglas P Mortlock; Thomas A Einhorn; Louis C Gerstenfeld
Journal:  Bone       Date:  2012-02-25       Impact factor: 4.398

3.  Genetic sharing with coronary artery disease identifies potential novel loci for bone mineral density.

Authors:  Cheng Peng; Jie Shen; Xu Lin; Kuan-Jui Su; Jonathan Greenbaum; Wei Zhu; Hui-Ling Lou; Feng Liu; Chun-Ping Zeng; Wei-Feng Deng; Hong-Wen Deng
Journal:  Bone       Date:  2017-06-23       Impact factor: 4.398

4.  Increased risk of coronary heart disease in patients with hip fracture: a nationwide cohort study.

Authors:  C-H Tsai; C-L Lin; H-C Hsu; W-S Chung
Journal:  Osteoporos Int       Date:  2015-03-24       Impact factor: 4.507

5.  Fasudil Ameliorates Osteoporosis Following Myocardial Infarction by Regulating Cardiac Calcitonin Secretion.

Authors:  Chengyu Xiang; Yeqian Zhu; Maohua Xu; Dingguo Zhang
Journal:  J Cardiovasc Transl Res       Date:  2022-05-12       Impact factor: 4.132

6.  Increased risk of cardiovascular events in end-stage renal disease patients with osteoporosis: a nationwide population-based cohort study.

Authors:  T-M Yu; C-L Lin; K-H Shu; Y-L Liu; C-H Chen; S-T Huang; C-H Kao
Journal:  Osteoporos Int       Date:  2014-12-10       Impact factor: 4.507

7.  Circulating levels of carboxy‐methyl‐lysine (CML) are associated with hip fracture risk: the Cardiovascular Health Study.

Authors:  Joshua I Barzilay; Petra Bůžková; Susan J Zieman; Jorge R Kizer; Luc Djoussé; Joachim H Ix; Russell P Tracy; David S Siscovick; Jane A Cauley; Kenneth J Mukamal
Journal:  J Bone Miner Res       Date:  2014       Impact factor: 6.741

8.  Albuminuria and rapid loss of GFR and risk of new hip and pelvic fractures.

Authors:  Joshua I Barzilay; Peggy Gao; Catherine M Clase; Andrew Mente; Johannes F E Mann; Peter Sleight; Salim Yusuf; Koon K Teo
Journal:  Clin J Am Soc Nephrol       Date:  2012-11-26       Impact factor: 8.237

9.  Application of polyunsaturated fatty acids in internal medicine: beyond the established cardiovascular effects.

Authors:  Arrigo F G Cicero; Alessandra Reggi; Angelo Parini; Claudio Borghi
Journal:  Arch Med Sci       Date:  2012-11-07       Impact factor: 3.318

10.  Coronary microvascular endothelial dysfunction is an independent predictor of development of osteoporosis in postmenopausal women.

Authors:  Megha Prasad; Martin Reriani; Sundeep Khosla; Mario Gössl; Ryan Lennon; Rajiv Gulati; Abhiram Prasad; Lilach O Lerman; Amir Lerman
Journal:  Vasc Health Risk Manag       Date:  2014-08-26
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.